The Replacement of Only One Portion of Starchy Carbohydrates with Green Leafy Vegetables Regresses Mid and Advanced Stages of NAFLD: Results from a Prospective Pilot Study
-
Published:2023-05-12
Issue:10
Volume:15
Page:2289
-
ISSN:2072-6643
-
Container-title:Nutrients
-
language:en
-
Short-container-title:Nutrients
Author:
De Nucci Sara1, Rinaldi Roberta1ORCID, Di Chito Martina1, Donghia Rossella2ORCID, Giannuzzi Vito3, Shahini Endrit3ORCID, Cozzolongo Raffaele3, Pesole Pasqua Letizia4ORCID, Coletta Sergio4, De Pergola Giovanni1, Giannelli Gianluigi5ORCID
Affiliation:
1. Unit of Geriatrics and Internal Medicine, National Institute of Gastroenterology—IRCCS “Saverio de Bellis”, Via Turi 27, 70013 Castellana Grotte, Bari, Italy 2. Unit of Data Science, National Institute of Gastroenterology—IRCCS “Saverio de Bellis”, Via Turi 27, 70013 Castellana Grotte, Bari, Italy 3. Department of Gastroenterology, National Institute of Gastroenterology—IRCCS “Saverio de Bellis”, Via Turi 27, 70013 Castellana Grotte, Bari, Italy 4. National Institute of Gastroenterology—IRCCS “Saverio de Bellis”, Via Turi 27, 70013 Castellana Grotte, Bari, Italy 5. Scientific Direction, National Institute of Gastroenterology—IRCCS “Saverio de Bellis”, Via Turi 27, 70013 Castellana Grotte, Bari, Italy
Abstract
The gold standard treatment for NAFLD is weight loss and lifestyle interventions, which require a diet enriched in fiber and reduced in sugars and saturated fats. Fibres may be advantageous for NAFLD patients since they reduce and slow the absorption of carbohydrates, lipids, and proteins, lowering the energy density of the meal and increasing their sense of satiety. Furthermore, the polyphenol content and other bioactive compounds of vegetables have antioxidant and anti-inflammatory properties preventing disease progression. The aim of this study is to ascertain the effects of a diet enriched by green leafy vegetables and with a moderate restriction of carbohydrate intake in patients with NAFLD over a three month period. Among the forty patients screened, twenty four patients completed the clinical trial consisting of swapping one portion of carbohydrate-rich food for one portion of green leafy vegetables, and liver and metabolic markers of NAFLD were evaluated. All patients underwent routine blood tests, anthropometric measurements, bioelectrical impedance analysis, fibroscan, and fatty liver index (FLI) evaluation before and at the end of the study. The population under study (n = 24) had a median age of 47.5 (41.5–52.5) years and included mainly women (70.8%). We found that FLI, which is used to predict fatty liver (73 (33–89) vs. 85 (54–95), p < 0.0001) and the FAST score, which is a fibroscan-derived parameter identifying patients at risk of progressive NASH (0.03 (0.02–0.09) vs. 0.05 (0.02–0.15), p = 0.007), were both improved after changes in diet. The BMI (33.3 (28.6–37.3) vs. 35.3 (31.2–39.0), p < 0.0001), WC (106.5 (95.0–112.5) vs. 110.0 (103.0–124.0), p < 0.0001), neck circumference (38.0 (35.0–41.5) vs. 39.5 (38.0–42.5), p < 0.0001), fat mass (32.3 (23.4–40.7) vs. 37.9 (27.7–43.5), p < 0.0001), and extracellular water (17.3 (15.2–20.8) vs. 18.3 (15.9–22.7), p = 0.03) were also all significantly lower after three months of diet. Metabolic parameters linked to NAFLD decreased: HbA1c (36.0 (33.5–39.0) vs. 38.0 (34.0–40.5), p = 0.01), triglycerides (72 (62–90) vs. 90 (64–132), p = 0.03), and the liver markers AST (17 (14–19) vs. 18 (15–27), p = 0.01) and γGT (16 (13–20) vs. 16 (14–27), p = 0.02). In conclusion, replacing only one portion of starchy carbohydrates with one portion of vegetables for a three month period is sufficient to regress, at least in part, both mid and advanced stages of NAFLD. This moderate adjustment of lifestyle habits is easily achievable.
Funder
Italian Ministry of Health with Ricerca Corrente 2021
Subject
Food Science,Nutrition and Dietetics
Reference45 articles.
1. Le, M.H., Yeo, Y.H., Li, X., Li, J., Zou, B., Wu, Y., Ye, Q., Huang, D.Q., Zhao, C., and Zhang, J. (2021). 2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis. Clin. Gastroenterol. Hepatol., 20. 2. The prevalence and incidence of NAFLD worldwide: A systematic review and meta-analysis;Riazi;Lancet,2022 3. Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis;Younossi;Hepatology,2019 4. Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention;Younossi;Nat. Rev. Gastroenterol. Hepatol.,2017 5. Metabolic aspects of adult patients with nonalcoholic fatty liver disease;Abenavoli;World J. Gastroenterol.,2016
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|